1. Home
  2. CYCN vs MITQ Comparison

CYCN vs MITQ Comparison

Compare CYCN & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • MITQ
  • Stock Information
  • Founded
  • CYCN 2018
  • MITQ N/A
  • Country
  • CYCN United States
  • MITQ United States
  • Employees
  • CYCN N/A
  • MITQ N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • MITQ Telecommunications Equipment
  • Sector
  • CYCN Health Care
  • MITQ Telecommunications
  • Exchange
  • CYCN Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • CYCN 8.4M
  • MITQ 8.0M
  • IPO Year
  • CYCN N/A
  • MITQ 2021
  • Fundamental
  • Price
  • CYCN $3.12
  • MITQ $0.73
  • Analyst Decision
  • CYCN
  • MITQ
  • Analyst Count
  • CYCN 0
  • MITQ 0
  • Target Price
  • CYCN N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • CYCN 5.8M
  • MITQ 180.0K
  • Earning Date
  • CYCN 03-04-2025
  • MITQ 02-13-2025
  • Dividend Yield
  • CYCN N/A
  • MITQ N/A
  • EPS Growth
  • CYCN N/A
  • MITQ N/A
  • EPS
  • CYCN N/A
  • MITQ N/A
  • Revenue
  • CYCN $194,000.00
  • MITQ $18,932,000.00
  • Revenue This Year
  • CYCN N/A
  • MITQ N/A
  • Revenue Next Year
  • CYCN N/A
  • MITQ N/A
  • P/E Ratio
  • CYCN N/A
  • MITQ N/A
  • Revenue Growth
  • CYCN N/A
  • MITQ N/A
  • 52 Week Low
  • CYCN $1.27
  • MITQ $0.42
  • 52 Week High
  • CYCN $9.47
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 46.78
  • MITQ 48.33
  • Support Level
  • CYCN $2.81
  • MITQ $0.68
  • Resistance Level
  • CYCN $4.80
  • MITQ $0.78
  • Average True Range (ATR)
  • CYCN 0.76
  • MITQ 0.05
  • MACD
  • CYCN -0.08
  • MITQ -0.01
  • Stochastic Oscillator
  • CYCN 20.76
  • MITQ 48.86

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: